1. Home
  2. MDXH vs MQT Comparison

MDXH vs MQT Comparison

Compare MDXH & MQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXH
  • MQT
  • Stock Information
  • Founded
  • MDXH 2003
  • MQT 1992
  • Country
  • MDXH Belgium
  • MQT United States
  • Employees
  • MDXH N/A
  • MQT N/A
  • Industry
  • MDXH
  • MQT Investment Bankers/Brokers/Service
  • Sector
  • MDXH
  • MQT Finance
  • Exchange
  • MDXH Nasdaq
  • MQT Nasdaq
  • Market Cap
  • MDXH 203.4M
  • MQT 222.2M
  • IPO Year
  • MDXH 2021
  • MQT N/A
  • Fundamental
  • Price
  • MDXH $4.92
  • MQT $10.03
  • Analyst Decision
  • MDXH Buy
  • MQT
  • Analyst Count
  • MDXH 1
  • MQT 0
  • Target Price
  • MDXH $6.00
  • MQT N/A
  • AVG Volume (30 Days)
  • MDXH 274.6K
  • MQT 52.5K
  • Earning Date
  • MDXH 11-12-2025
  • MQT 01-01-0001
  • Dividend Yield
  • MDXH N/A
  • MQT 4.60%
  • EPS Growth
  • MDXH N/A
  • MQT N/A
  • EPS
  • MDXH N/A
  • MQT N/A
  • Revenue
  • MDXH $98,953,000.00
  • MQT N/A
  • Revenue This Year
  • MDXH $24.43
  • MQT N/A
  • Revenue Next Year
  • MDXH $21.00
  • MQT N/A
  • P/E Ratio
  • MDXH N/A
  • MQT N/A
  • Revenue Growth
  • MDXH 22.56
  • MQT N/A
  • 52 Week Low
  • MDXH $1.35
  • MQT $8.59
  • 52 Week High
  • MDXH $5.33
  • MQT $10.67
  • Technical
  • Relative Strength Index (RSI)
  • MDXH 64.64
  • MQT 46.79
  • Support Level
  • MDXH $4.71
  • MQT $9.95
  • Resistance Level
  • MDXH $5.33
  • MQT $10.13
  • Average True Range (ATR)
  • MDXH 0.30
  • MQT 0.08
  • MACD
  • MDXH 0.05
  • MQT -0.02
  • Stochastic Oscillator
  • MDXH 72.11
  • MQT 26.67

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

About MQT Blackrock MuniYield Quality Fund II Inc.

BLACKROCK MUNIYIELD QUALITY FUND II, INC. is a closed-end fund. Its objective is to provide shareholders with as high a level of current income exempt from federal income taxes as is consistent with its investment policies and prudent investment management. It invests in various sectors such as Transportation, Utilities, Health, County/City/Special District/School District, Education, Housing, Corporate, and Tobacco.

Share on Social Networks: